Order-made Medical Research

Order-made Medical Research Inc. (OMR) is a Japanese biotech company founded in 2012 that develops revolutionary therapeutic antibody technologies using its proprietary LIMAXYS production platform. The company has pioneered methods to generate high-quality antibodies against multi-transmembrane and intracellular target molecules that were previously difficult to address, expanding the druggable target space for therapeutic antibodies. OMR pursues a licensing-focused business model, out-licensing discovered antibody candidates to pharmaceutical and biotech companies at early R&D stages.